<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05012046</url>
  </required_header>
  <id_info>
    <org_study_id>REB: 2021-177</org_study_id>
    <nct_id>NCT05012046</nct_id>
  </id_info>
  <brief_title>Effect of 100% Orange Juice on Food Intake and Glycemic Response in Adults</brief_title>
  <official_title>Effect of 100% Orange Juice Intake on Subjective Appetite, Food Intake, Glycemic Response and Subjective Mood in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ryerson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ryerson University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of 100% orange juice on short-term food&#xD;
      intake (FI), satiety, post-prandial glycemia and mood in healthy adults. We hypothesize that&#xD;
      the consumption of 100% orange juice in the pre-meal environment will improve satiety signals&#xD;
      and mood, and suppress FI through its effect on post-prandial glycemia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized within-subjects repeated measures design will be employed. Study visits will&#xD;
      take place in the morning, separated one-week apart. At each session, participants will&#xD;
      consume one of three treatments: 1) 100% orange juice; 2) orange flavoured drink; or 3)&#xD;
      water. Glycemic response will be measured for 60 minutes (baseline (0 minutes), 15 minutes,&#xD;
      30 minutes, 45 minutes and 60 minutes) post-treatment via finger prick. Blood glucose&#xD;
      measures will also be provided over 24 hours via a Dexcom G6 continuous glucose monitoring&#xD;
      (CGM) device. Subjective appetite, emotions and mood will be measured for 90 minutes min&#xD;
      (baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, 60 minutes and 90 minutes)&#xD;
      post-treatment. At 60 minutes, participants will consume an ad libitum pizza lunch to&#xD;
      evaluate food intake. After lunch, participants will be sent home with a rest-of-the-day food&#xD;
      intake sheet to record their snacks, meals, and beverages, as well as a physical activity log&#xD;
      to record their physical activity for the rest of the day following test session completion.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline glycemic response (acute phase)</measure>
    <time_frame>Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption</time_frame>
    <description>Blood glucose (mmol/L). Three drops of blood from the finger will be collected at each time point using a single-use, auto-disabling lancet device and sodium fluoride/potassium oxalate capillary blood collection tubes. Blood glucose will be measured using a YSI 2900D Biochemistry Analyzer (YSI Inc., Yellow Springs, OH).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rest-of-day blood glucose concentrations</measure>
    <time_frame>Continuous measurements for 24 hours post-treatment consumption</time_frame>
    <description>Blood glucose (mmol/L). Rest-of-day blood glucose concentrations will be determined using a Dexcom G6 CGM system.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ad libitum food intake</measure>
    <time_frame>At 60 minutes post-treatment consumption</time_frame>
    <description>Lunch pizza meal. Food intake will be determined by weighing the meal before and after serving. The net weight of the test meal will be converted to calories.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline subjective appetite</measure>
    <time_frame>Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption</time_frame>
    <description>Measured using visual analogue scales (VAS). Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings. Questions will include desire to eat, fullness, hunger, and prospective food consumption. Individual questions will be used to form a composite score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline subjective emotions and mood</measure>
    <time_frame>Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption</time_frame>
    <description>Measured using visual analogue scales. Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings. Questions will measure aggression, anger, excitement, disappointment, frustration, alertness, sadness, tension, effort, happiness, weariness, calmness, sleepiness, and wellness. Individual questions will be used to form a composite score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rest-of-the-day food intake</measure>
    <time_frame>For the rest of the day following test session completion (1 day)</time_frame>
    <description>Participants will be sent home with a rest-of-the-day food intake recall sheet to record their snacks, meals, and beverages.&#xD;
Rest of day food log</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rest-of-the-day physical activity</measure>
    <time_frame>For the rest of the day following test session completion (1 day)</time_frame>
    <description>Participants will be sent home with a rest-of-the-day physical activity recall sheet to record any activities performed.&#xD;
Physical activity questionnaire</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Healthy</condition>
  <condition>Adult</condition>
  <condition>Glycemic Response</condition>
  <condition>Appetite</condition>
  <arm_group>
    <arm_group_label>Orange juice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment beverage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Orange flavoured drink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment beverage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Water</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment beverage</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Orange juice</intervention_name>
    <description>Matched for volume (240 mL/ 8 oz) of other test beverages. 100% orange juice (Tropicana Pure Premium Original, No Pulp) will provide 110 calories.</description>
    <arm_group_label>Orange juice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Orange flavoured drink</intervention_name>
    <description>Matched for volume (240 mL/ 8 oz) of other test beverages. Orange flavoured drink (Fruité® Orange Drink) will provide 96 calories.</description>
    <arm_group_label>Orange flavoured drink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water</intervention_name>
    <description>Matched for volume (240 mL/ 8 oz) of other test beverages. Control beverage (no caloric contribution).</description>
    <arm_group_label>Water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  aged 18-45 years;&#xD;
&#xD;
          -  within the healthy body mass index (BMI) range for adults of 18.5-24.9 kg/m2.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  individuals who are dieting;&#xD;
&#xD;
          -  restrained eaters;&#xD;
&#xD;
          -  breakfast skippers;&#xD;
&#xD;
          -  those who dislike breakfast or lunch treatment foods;&#xD;
&#xD;
          -  those taking medication;&#xD;
&#xD;
          -  individuals with any metabolic disorders or significant weight fluctuations.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nick Bellissimo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ryerson University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nick Bellissimo, PhD</last_name>
    <phone>4169795000</phone>
    <phone_ext>553026</phone_ext>
    <email>nick.bellissimo@ryerson.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre for Urban Innovation (CUI-109), School of Nutrition, Ryerson University</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 2K3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nick Bellissimo, PhD</last_name>
      <phone>416 979 5000</phone>
      <phone_ext>553026</phone_ext>
      <email>nick.bellissimo@ryerson.ca</email>
    </contact>
    <investigator>
      <last_name>Nick Bellissimo, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 11, 2021</study_first_submitted>
  <study_first_submitted_qc>August 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2021</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ryerson University</investigator_affiliation>
    <investigator_full_name>Nick Bellissimo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Food intake</keyword>
  <keyword>Appetite</keyword>
  <keyword>Blood glucose</keyword>
  <keyword>Glycemic response</keyword>
  <keyword>Orange juice</keyword>
  <keyword>Adults</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

